首页> 外国专利> the use of adenosiini and its analogues for treatment of insulin resistance syndrome jadiabeedi product

the use of adenosiini and its analogues for treatment of insulin resistance syndrome jadiabeedi product

机译:腺苷及其类似物在胰岛素抵抗综合症贾迪阿比迪产品中的用途

摘要

The invention relates to the use of adenosine compounds described by formula I CHEM and certain derivatives thereof for producing a medicine for the treatment of the insulin resistance syndrome and diabetes. In the formula I K is N, N-O, or CH; Q is CH2 or O; R6 is hydrogen, alkyl, allyl, 2-methallyl, 2-butenyl, or cycloalkyl; CHEM E is O or S; Y is e.g. hydrogen, alkyl, aralkyl, aryl; n and p are independently 0, 1, 2, or 3, provided that n + p is at least 1; T is e.g hydrogen, alkyl, acyl, thioacyl, halo, carboxyl; R1, R2 and R3 are independently H, alkyl, or cycloalkyl; A is hydrogen, alkyl, hydroxyalkyl, alkoxyalkyl, or OR'; B is hydrogen, alkyl, hydroxyalkyl, alkoxyalkyl, or OR"; R' and R" are e.g independently hydrogen, alkyl, aralkyl or carbamoyl.
机译:本发明涉及式I 描述的腺苷化合物及其某些衍生物在制备用于治疗胰岛素抵抗综合症和糖尿病的药物中的用途。在式中,I K为N,N-> O或CH; Q是CH2或O; R6是氢,烷基,烯丙基,2-甲基烯丙基,2-丁烯基或环烷基; E为O或S; Y是例如氢,烷基,芳烷基,芳基; n和p独立为0、1、2或3,前提是n + p至少为1; T是例如氢,烷基,酰基,硫代酰基,卤素,羧基; R1,R2和R3独立地为H,烷基或环烷基; A为氢,烷基,羟烷基,烷氧基烷基或OR'; B是氢,烷基,羟烷基,烷氧基烷基或OR”; R′和R”例如独立地是氢,烷基,芳烷基或氨基甲酰基。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号